Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer
- PMID: 33735874
- PMCID: PMC8448803
- DOI: 10.1159/000513925
Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer
Abstract
CML is defined by the presence of an oncogenic fusion protein caused by a reciprocal translocation between chromosomes 9q and 22q. While our molecular understanding of CML pathogenesis has revolutionized drug development for this disease, we have yet to identify many predisposing factors for CML. Familial occurrence of CML has been rarely reported. Here, we describe 2 cases of CML in a 24-year-old woman and in her 73-year-old maternal great aunt. We describe genetic variants in these patients and report on their environmental exposures that may have contributed to CML pathogenesis. The possible familial association of these 2 cases of CML warrants further investigation into more definitive etiologies of this disease.
Keywords: Chronic myeloid leukemia; Familial cancer; Hereditary cancer syndromes.
© 2021 S. Karger AG, Basel.
Conflict of interest statement
Conflict of Interest Statement
The authors have no conflicts of interest to declare.
Figures

Similar articles
-
BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.Cancer Genet. 2021 Jun;254-255:70-74. doi: 10.1016/j.cancergen.2021.02.007. Epub 2021 Feb 19. Cancer Genet. 2021. PMID: 33647814
-
Double insertion in normal karyotype CML.Blood. 2021 Apr 29;137(17):2418. doi: 10.1182/blood.2021010829. Blood. 2021. PMID: 33914075 No abstract available.
-
A variant translocation (9;22;22) with local extramedullary monoblastic transformation in CML.Cancer Genet Cytogenet. 2000 Nov;123(1):69-70. doi: 10.1016/s0165-4608(00)00302-2. Cancer Genet Cytogenet. 2000. PMID: 11188768 No abstract available.
-
The molecular biology of chronic myeloid leukaemia.Leukemia. 1996 May;10(5):751-6. Leukemia. 1996. PMID: 8656667 Review.
-
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia.Genes Chromosomes Cancer. 2005 Nov;44(3):329-33. doi: 10.1002/gcc.20235. Genes Chromosomes Cancer. 2005. PMID: 16001431 Review.
Cited by
-
Chromosomal Instability in Chronic Myeloid Leukemia: Mechanistic Insights and Effects.Cancers (Basel). 2022 May 21;14(10):2533. doi: 10.3390/cancers14102533. Cancers (Basel). 2022. PMID: 35626137 Free PMC article. Review.
-
Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia.Front Oncol. 2022 Oct 6;12:1021662. doi: 10.3389/fonc.2022.1021662. eCollection 2022. Front Oncol. 2022. PMID: 36276124 Free PMC article. Review.
-
Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population.BMC Cancer. 2024 Jun 14;24(1):734. doi: 10.1186/s12885-024-12102-2. BMC Cancer. 2024. PMID: 38877512 Free PMC article.
-
Familial Acute Promyelocytic Leukemia: A Case Report and Review of the Literature.Onco Targets Ther. 2024 Sep 4;17:733-738. doi: 10.2147/OTT.S482781. eCollection 2024. Onco Targets Ther. 2024. PMID: 39247121 Free PMC article.
References
-
- Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973June1;243(5405):290–3. - PubMed
-
- Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 1985June13–19315(6020):550–4. - PubMed
-
- Druker BJ, Guilhot F, O’Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al.Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006December7;355(23):2408–17. - PubMed
-
- Ross DM, Branford S, Seymour JF, Schwarer AP, Arthur C, Yeung DT, et al.Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study. Blood. 2013July25;122(4):515–22. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical